Cibus (CBUS) Short term Debt (2016 - 2026)
Cibus (CBUS) posted Short term Debt of $435000.0 for Q4 2025, down 34.29% sequentially from $662000.0 in Q3 2025, and little changed YoY from $436000.0 in Q4 2024.
Cibus (CBUS) Short term Debt (2016 - 2026) Analysis & Trends
Cibus has reported Short term Debt for 10 years, with the latest figure at $435000.0 in Q4 2025.
- Quarterly Short term Debt changed 0.23% year-over-year to $435000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $435000.0 (changed 0.23% YoY) and the FY2025 annual result came in at $435000.0, changed 0.23% from the prior year.
- Short term Debt declined to $435000.0 in Q4 2025 per CBUS's latest filing, from $662000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $1.6 million in Q2 2023 and troughed at $64000.0 in Q1 2022.
- A 5-year average of $501421.1 and a median of $404000.0 in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2021 and 2023: Short term Debt tumbled 79.42% in 2021, then jumped 1462.5% in 2023.
- Over 5 years, Short term Debt stood at $172000.0 in 2021, then slipped by 19.77% to $138000.0 in 2022, then jumped by 503.62% to $833000.0 in 2023, then tumbled by 47.66% to $436000.0 in 2024, then fell by 0.23% to $435000.0 in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $435000.0, $662000.0, and $966000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 812,000.00 |
| Dec 31, 2025 | 435,000.00 |
| Sep 30, 2025 | 662,000.00 |
| Jun 30, 2025 | 966,000.00 |
| Mar 31, 2025 | 334,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 404,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 833,000.00 |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Sep 30, 2022 | 138,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Sep 30, 2021 | 149,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 114,000.00 |